Related Experiment Video
Updated: Mar 26, 2026

07:24
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.9K
Long Noncoding RNA MALAT-1 Can Predict Poor Prognosis: A Meta-Analysis.
Ruixue Tang1, Mengtong Jiang1, Lu Liang1
1Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang, China (mainland).
Summary
High MALAT-1 expression indicates poor prognosis in various cancers. This meta-analysis confirms its role as a potential prognostic indicator for overall and disease-free survival.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MALAT-1 is a conserved nuclear long non-coding RNA (lncRNA).
- Overexpression of MALAT-1 is observed in several cancer types.
- Its prognostic significance in cancer requires further investigation.
Purpose of the Study:
- To evaluate MALAT-1 as a prognostic indicator in various human cancers.
- To synthesize evidence from existing studies through meta-analysis.
- To determine the association between MALAT-1 expression and patient survival outcomes.
Main Methods:
- Systematic literature search across 13 databases up to June 30, 2015.
- Meta-analysis of 17 studies including 1626 patients.
- Calculation of combined hazard ratios (HRs) with 95% confidence intervals (CIs) using fixed- or random-effects models.
- Quality assessment of studies using the Newcastle-Ottawa Scale (NOS).
Main Results:
- High MALAT-1 expression is significantly associated with poor overall survival (OS) (HR=1.84, 95% CI: 1.27-2.67).
- High MALAT-1 expression is also linked to poorer disease-free survival (DFS) (HR=2.37, 95% CI: 1.55-3.62).
- These associations were consistent across subgroups, including country-specific analyses (e.g., China: HR=1.85, 95% CI: 1.14-2.99).
Conclusions:
- Overexpression of MALAT-1 serves as a potential prognostic biomarker for diverse human cancers.
- MALAT-1 warrants further clinical investigation for its role in cancer prognosis.
- The findings support MALAT-1 as a valuable indicator of survival outcomes in cancer patients.
Related Concept Videos
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
Non-LTR Retrotransposons
14.0K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K
MicroRNAs
24.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
